Effects of Hemodialysis on the Sleep/Wake Cycle
3 other identifiers
interventional
58
1 country
1
Brief Summary
The purpose of this study is to test a novel application of an existing treatment - using col dialysate (often used to treat hypotension) as opposed to warm dialysate (standard treatment) during hemodialysis for its ability to stabilize the sleep/wake cycle of patients receiving this chronic treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Apr 2003
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
April 16, 2007
CompletedFirst Posted
Study publicly available on registry
April 17, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedApril 24, 2014
May 1, 2008
4.7 years
April 16, 2007
April 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Polysomnographic measures of sleep
At three time points over the nine month study period
Polysomnographic measures of daytime sleepiness
At three time points over the nine month study period
Distal/proximal skin temperature gradient
At three time points during the nine month study period
Secondary Outcomes (5)
Subjective measure of sleep quality
Monthly during the nine month study period
Subjective measure of daytime sleepiness
Monthly during the nine month study period
Subjective measure of mood
Monthly during the nine month study period
Subjective measure of quality of life
Monthly during the nine month study period
Subjective measure of functional health status
Monthly during the nine month study period
Interventions
Eligibility Criteria
You may qualify if:
- All races
- Cause of renal failures - diabetes, hypertension, glomerulonephritis, or polycystic kidney disease
- Ability to read and write in English hemodialysis three times a week for at least 4 months
- Clinically stable
- KT/V \> 1.0
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathy P Parker, PhD
Emory University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 16, 2007
First Posted
April 17, 2007
Study Start
April 1, 2003
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
April 24, 2014
Record last verified: 2008-05